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he mechanism by which capping protein (CP) binds
barbed ends of actin ﬁlaments is not understood, and
the physiological signiﬁcance of CP binding to actin
is not deﬁned. The CP crystal structure suggests that the
COOH-terminal regions of the CP 
 
 
 
 and 
 
 
 
 subunits bind to
the barbed end. Using puriﬁed recombinant mutant yeast
CP, we tested this model. CP lacking both COOH-terminal
regions did not bind actin. The 
 
 
 
 COOH-terminal region
was more important than that of 
 
 
 
. The signiﬁcance of CP’s
T
 
actin-binding activity in vivo was tested by determining
how well CP actin-binding mutants rescued null mutant
phenotypes. Rescue correlated well with capping activity,
as did localization of CP to actin patches, indicating that
capping is a physiological function for CP. Actin ﬁlaments
of patches appear to be nucleated ﬁrst, then capped with
CP. The binding constants of yeast CP for actin suggest that
actin capping in yeast is more dynamic than in vertebrates.
 
Introduction
 
In vitro, capping protein (CP) caps the barbed end of the actin
filament (Cooper et al., 1999) and is an essential component
for the reconstitution of movement powered by actin poly-
merization (Loisel et al., 1999). CP is expressed in all eukaryotic
organisms, from plasmodia to yeasts to mammals. In vivo,
CP is important for actin assembly and cell motility (Cooper
et al., 1999).
 
Saccharomyces cerevisiae
 
 CP is a stable heterodimer with
subunits of 
 
M
 
r
 
 32 (the 
 
 
 
 subunit, Cap1) and 33.7 (the 
 
 
 
subunit, Cap2), each encoded by one gene (Amatruda and
Cooper, 1992; Amatruda et al., 1992). CP is located on
cortical actin patches in vivo. In CP null mutant cells, actin
patches are present, but depolarized (Amatruda and Cooper,
1992; Amatruda et al., 1992). In addition, CP null mutations
 
are synthetic lethal with null mutations in 
 
SAC6
 
, which
encodes fimbrin, another protein of the actin patch (Adams
et al., 1993). CP is necessary for the localization of twinfilin
to actin patches, through a direct interaction (Palmgren et
al., 2001).
The crystal structure of chicken CP inspired a “tentacle”
model in which the COOH-terminal regions of each sub-
unit are proposed to extend out to interact with barbed ends
of actin filaments (Yamashita et al., 2003). In that structure,
the 
 
 
 
 and 
 
 
 
 subunits have similar secondary and tertiary
structures, giving the molecule a pseudo twofold rotational
axis of symmetry. The overall shape resembles a mushroom,
with a stalk and cap. A bundle of six anti-parallel 
 
 
 
-helices,
three from the NH
 
2
 
 terminus of each subunit, comprise the
mushroom stalk. Next are short stretches of 
 
 
 
-strand and
reverse turns lying to the side of the stalk and under the
mushroom cap. The central region of the protein includes a
single 10-stranded anti-parallel 
 
 
 
-sheet. Atop this 
 
 
 
-sheet
are two long 
 
 
 
-helices, running anti-parallel to each other.
Finally, each subunit has a COOH-terminal extension
proposed to function as a flexible tentacle, reaching out to
interact with the barbed end of the actin filament. Each
 
COOH-terminal region contains a short amphipathic 
 
 
 
-helix.
 
The tentacle model was supported by a structure/function
analysis of chicken CP, in which the actin-binding activities
of recombinant mutant chicken CPs were tested (Wear et al.,
2003). Here, we tested the tentacle model for yeast CP, using
a similar approach. We used a structure for yeast CP pre-
pared by homology modeling from the chicken CP structure.
More importantly, we used the resulting CP actin-binding
mutants to test the functional significance of the actin-
capping activity of CP in vivo. We assayed the function of
the mutant CPs in vivo by testing their ability to rescue null
phenotypes. We also determined the localization of the
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mutant CPs in vivo. Actin-capping activity in vitro corre-
lated well with the function and localization of CP in vivo,
providing insight into the mechanism of actin assembly and
motility along with the function of CP.
 
Results
 
A homology model structure for yeast CP
 
To create a structure for yeast CP, we used SWISS-MODEL
(Guex and Peitsch, 1997) to perform homology modeling
with the chicken CP structure (Yamashita et al., 2003) as a
template. The resulting yeast CP model structure is similar
to that of chicken CP, as expected (Fig. 1 A). In particular,
the COOH-terminal sequence of each subunit has a short
region of amphipathic 
 
 
 
-helix as part of the proposed tenta-
cle. At the base of the tentacle are conserved basic residues
(Arg239 in Cap1 and Lys261 in Cap2) that may function in
tentacle structure or mobility.
 
Testing the tentacle model
 
To test the tentacle model, we made mutations in the
COOH-terminal regions of each subunit, expressed mu-
tant CP in bacteria, and purified the protein (Fig. 2). To
test actin-capping activity, we measured the kinetics of
actin polymerization from barbed ends using spectrin-
F-actin seeds. For a quantitative comparison of the mutants,
binding affinity and kinetic rate constants were determined
by modeling the time course of the polymerization reac-
tion. We also measured the effect of mutant CPs on the
apparent critical concentration for actin polymerization at
steady state. In this assay, capping the barbed end increases
the critical concentration to that of the pointed end, pro-
ducing a plateau, whereas monomer sequestration increases
the critical concentration indefinitely. Again, modeling
 
was used to analyze the results quantitatively and to com-
pare the mutant CPs.
First, we measured the capping activity of wild-type (wt)
CP (Cap1/Cap2) with yeast and muscle actin. In both cases,
CP inhibited actin polymerization nucleated by spectrin-
F-actin seeds, and a simple capping model produced good fits
(Fig. 3, A and B). From the modeling, the K
 
d
 
 for capping was
1.2 and 3.5 nM for muscle and yeast actin, respectively (Table
I). In the critical concentration assay, the K
 
d
 
s for yeast and
muscle actin barbed ends were 4 and 6.25 nM, respectively
(see Fig. 5 A, diamond; Fig. 5 B, square; Table I). The on-rate
constant (8.9 
 
 
 
M
 
 
 
1
 
s
 
 
 
1
 
) and off-rate constant (3.16 
 
 
 
10
 
 
 
2
 
s
 
 
 
1
 
) for CP binding to yeast actin were somewhat higher
than those with muscle actin (1.16 
 
 
 
M
 
 
 
1
 
s
 
 
 
1
 
 and 1.56 
 
 
 
10
 
 
 
3
 
s
 
 
 
1
 
, respectively). Muscle actin was used to test all the CP
mutants, and crucial results were confirmed with yeast actin.
 
Removal of both COOH-terminal regions
 
The tentacle model predicts that loss of both COOH-termi-
nal regions should cause a complete loss of actin binding. To
test this prediction, we expressed and purified a mutant CP
lacking the COOH-terminal 30 amino acids of Cap1 (R239-
K268) and the COOH-terminal 27 amino acids of Cap2
(K261-L287; Fig. 2). Cap1 R239 and Cap2 K261 are lo-
cated at the bases of the proposed tentacles in the mod-
eled CP structure (Fig. 1 A). The purified heterodimer,
Cap1(
 
 
 
239–268)/Cap2(
 
 
 
261–287), showed no inhibition
of actin polymerization in the seeded actin assembly assay at
concentrations up to 75 
 
 
 
M (Fig. 4 A), or in the critical con-
centration assay at concentrations up to 50 
 
 
 
M (Fig. 5 C,
closed circle). The calculated lower limit of the capping K
 
d
 
was 100 
 
 
 
M. We also tested a mutant with a slightly shorter
Cap2 truncation, 24 amino acids, combined with the same
Cap1 truncation, Cap1(
 
 
 
239–268)/Cap2(
 
 
 
264–287). This
heterodimer mutant showed a very small effect in the seeded
actin assembly assay, with a K
 
d
 
 of 33.4 
 
 
 
M (Table I).
 
The CP 
 
 
 
 (Cap1) COOH-terminal region
 
To test the importance of the proposed Cap1 tentacle in actin
capping, we tested a mutant lacking the COOH-terminal 30
Figure 1. A model structure for yeast CP. (A) Cap1 and Cap2 are 
colored yellow and red, respectively, except that their proposed 
tentacles are cyan and green, respectively. Certain residues targeted 
for mutation are indicated. Cap2 residues 268–273 could not be 
modeled and are indicated as a dashed line. Arrowhead indicates 
amphipathic  -helix in the COOH-terminal region of the   subunit. 
(B) Alignment of the COOH-terminal regions of CP   in various 
species. Residues found in all species are colored blue.
Figure 2. Purified recombinant CP preparations. A portion of a 10% 
SDS–polyacrylamide gel stained with Coomassie Blue is shown. 
No other bands were present, above or below this region. 
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amino acids of Cap1, R239-K268 (Fig. 2). In the seeded as-
sembly assay, Cap1(
 
 
 
239–268)/Cap2 inhibited actin poly-
merization, but only at high concentrations. The data were fit
well by a simple capping model (Fig. 4 B). The K
 
d
 
 for capping
was 10.3 
 
 
 
M, 8,600-fold greater than that of wt CP (Table I).
In the critical concentration assay, the level of F-actin did not
change at concentrations of mutant CP up to 25 
 
 
 
M (Fig. 5
B, closed circle). The lower limit for the K
 
d
 
 was 50 
 
 
 
M. Thus,
the proposed Cap1 tentacle is very important for capping.
To test whether the Cap1 tentacle alone is sufficient to
bind actin, we assayed a synthetic peptide corresponding to
the COOH-terminal 30 amino acids of Cap1. The peptide
inhibited actin polymerization in the seeded assembly assay.
The data were fit well by a model that included both cap-
ping and monomer binding, but not by simpler models with
only capping or monomer binding (Fig. 4 C). From the
modeling, the capping K
 
d
 
 was 1.71 
 
 
 
M, with an on-rate
constant of 0.0021 
 
 
 
M
 
 
 
1
 
s
 
 
 
1
 
 (Table I). For monomer bind-
ing, the K
 
d
 
 was 2.86 
 
 
 
M, and the on-rate constant was
0.0084 
 
 
 
M
 
 
 
1
 
s
 
 
 
1
 
. The peptide had no effect in the critical
concentration assay; however, concentrations of peptide 
 
 
 
8
 
 
 
M caused the formation of gross precipitates. Thus, the
proposed Cap1 tentacle sequence alone is sufficient to bind
actin, and even to cap barbed ends, albeit with low affinity.
Circular dichroism analyses of the free peptide showed no
secondary structure (unpublished data), so the active actin-
binding conformation of the tentacle may be promoted by
its connection to the body of the protein.
 
Point mutations in the Cap1 COOH-terminal region
 
The proposed tentacle for Cap1 includes an amphipathic
 
 
 
-helix (Fig. 1 A, arrowhead). The hydrophobic side in-
 
Table I. 
 
Binding and rate constants for the interaction of CP mutants and peptides with actin
Critical concentration experiment Seeded assembly experiment
CP species Actin K
 
d
 
K
 
d
 
k
 
 
 
2
 
k
 
 
 
2
 
nM
 
a
 
nM
 
b
 
 
 
M
 
 
 
1
 
s
 
 
 
1
 
s
 
 
 
1
 
 
 
 
 
 10
 
 
 
3
 
Wild type Muscle 4 1.2 1.16 1.56
Wild type Yeast 6.3 3.5 8.9 31.6
Cap1
 
 
 
(239–268)/Cap2 Muscle 10,300 0.00022 2.33
Cap1/Cap2
 
 
 
(261–287) Muscle 25 7.8 2.09 16.3
Cap1/Cap2
 
 
 
(261–287) Yeast 25 17 9.9 168
Cap1/Cap2
 
 
 
(264–287) Muscle 25 8 2.1 17
Cap1
 
 
 
(239–268)/Cap2
 
 
 
(264–287) Muscle 33,400 0.00037 12
Cap1 (W251A)/Cap2 Muscle 250 91 0.3 25.9
Cap1 (R239A)/Cap2 Muscle 400 176 0.156 27.5
Cap1 C-30 (peptide) Muscle 1,710 0.0021 3.6
 
a
 
The value of K
 
d
 
 was determined from the [CP] that changes the critical concentration by 50%, as described in the Materials and methods.
 
b
 
The K
 
d
 
 was calculated from the k
 
 
 
2
 
 (On) and k
 
 
 
2
 
 (Off) rate constants by modeling the time course of polymerization with reaction 2 (see Materials and
methods).
Figure 3. Effect of CP on seeded actin polymer-
ization: muscle vs. yeast actin. Experimental and 
fitted data are in black and red, respectively. (A) 
WT CP and muscle actin. (B) WT CP and yeast 
actin. (C) Cap1/Cap2( 261–287) and muscle actin. 
(D) Cap 1/Cap2( 261–287) and yeast actin. 
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cludes three highly conserved residues: W251, A254, and
I255. W251 is present in the CP   subunit of all species
(Fig. 1 B). We replaced W251 with alanine. Purified
Cap1(W251A)/Cap2 protein inhibited actin polymerization
in the seeded assembly assay (Fig. 4 D). A capping model fit
the data well. The Kd for capping was 91 nM, 76-fold less
than that of wt CP (Table I). The off-rate constant was in-
creased 17-fold, and the on-rate constant was decreased
fourfold. Capping was also seen in the critical concentration
assay, where the Kd was 250 nM (Fig. 5 D, triangle; Table
Figure 4. Effect of CP mutants on seeded actin 
polymerization. Experimental and fitted data are in 
black and red, respectively. (A) Cap1 (239–268)/
Cap2( 261–287). (B) Cap1 (239–268)/Cap2. (C) 
Cap1 C-30, a synthetic peptide corresponding to 
the Cap1 COOH-terminal 30 residues, 239–268. 
(D) Cap1 (W251A)/Cap2. (E) Cap1 (R239A)/Cap2.
Figure 5. Effect of CP mutants on the apparent 
critical concentration for actin polymerization at 
steady state. Pyrene actin fluorescence intensity, 
reflecting polymerized actin, is plotted vs. the log 
of the CP concentration. CP mutants are as indicated 
on each panel.Capping protein binding to actin | Kim et al. 571
I). Thus, W251 is important for capping. The residue may
be important for the structure of the tentacle, or it may in-
teract directly with actin.
The tentacle model predicts that the COOH-terminal re-
gions, the proposed tentacles, are mobile relative to the body
of the protein. The tentacle should pivot about its attach-
ment site. R239 is a highly conserved residue at this location
(Fig. 1, A and B). To test whether R239 is important for
capping, we replaced it with alanine. The Cap1 (R239A)/
Cap2 protein inhibited polymerization in the seeded assem-
bly assay (Fig. 4 E). A capping model gave a good fit, and
the Kd for capping was 176 nM, 150-fold higher than that
of wt (Table I). The on-rate constant was decreased 7.5-fold,
and the off-rate constant was increased 18-fold, relative to
wt. Capping was also seen in the critical concentration assay,
where the Kd was 400 nM (Fig. 5 D, circle; Table I). Thus,
the R239A mutation may affect the mobility or structure of
the tentacle, such that the tentacle does not properly interact
with actin filaments.
The CP   (Cap2) COOH-terminal region
We tested the tentacle model for CP   (Cap2) by removing
the COOH-terminal 27 amino acids, K261–L287, which
comprises the entire proposed tentacle. In a previous experi-
ment, a 21-aa truncation had normal actin-binding activity,
using partially purified protein from yeast and falling ball
viscometry (Sizonenko et al., 1996). Here, purified Cap1/
Cap2( 261–287) inhibited polymerization in the seeded as-
sembly assay, and a capping model fit the data well (Fig. 3 C).
With muscle actin, the Kd for capping was 7.8 nM, increased
approximately sevenfold from that of wt CP (Table I). The
difference was due almost entirely to an increase in the off-rate
constant. With yeast actin, the results were similar; the Kd was
17 nM, increased approximately fivefold from that of wt CP
(Fig. 3 D, Table I). In the steady-state critical concentration
assay, Cap1/Cap2( 261–287) exhibited capping activity,
with a Kd of 25 nM for both muscle and yeast actin (Fig. 5, A
and B; Table I). Increased concentrations, up to 10  M, did
not change the critical concentration further. A shorter trun-
cation of 24 residues produced similar results (Table I, Cap1/
Cap2( 264–287)). The proposed Cap2 tentacle alone, as a
free synthetic peptide and a GST fusion protein, had no actin-
binding activity (unpublished data). However, the synthetic
peptide showed no evidence of a secondary structure by circu-
lar dichroism. This region includes an amphipathic  -helix in
the homology model structure, so that feature may be neces-
sary for activity and may only exist when the tentacle is at-
tached to the protein. Overall then, the proposed tentacle of
Cap2 is necessary for high affinity capping, but the proposed
tentacle of Cap1 is much more important.
Function and localization of CP mutants in vivo
We assayed the ability of a number of CP mutants to func-
tion in cells, motivated by two major goals. First, actin cap-
Table II. Compilation of data on CP function
Mutation Actin capping Kd Actin 
polarization
a
Growth in sac6 
background
b
CP localization 
pattern
c
CP intensity 
at patches
d
wt 1 nM 81   3     Localizes at patches    
Cap2 K261A 89   2     wt    
Cap2 264–287 8 nM 86   2     wt    
Cap1 R241A 85   3     wt    
Cap1 S257R 83   3     ND
Cap2 261–287 82   3     wt    
Cap1 G256R 82   3     ND
Cap1 G252R 81   3     ND
Cap1 S253R 80   3     ND
Cap1 W251F 78   3     wt    
Cap1 A254R 76.5   3     wt    
Cap1 I255R 74   3     ND
Cap1 R240A 68   3     wt    
Cap1 258–268 62   3*    wt    
Cap1 W251A 91 nM 60   3*   Partial   
Cap1 W251R 46   4*   Partial   
Cap1 R239A 176 nM 39   3*   Diffuse  
Cap1 R239E 7   2* 0 Diffuse -
Cap1 R240E 5   2* 0 Diffuse -
Cap1 251–268 5   2* 0 Diffuse -
Cap1 239–268 10.3  M5     2* 0 Diffuse -
Cap1 RR239 240AA 4   1* 0 Diffuse -
Mutations are ranked by their value for actin polarization, with wt at top. Note that the rank order is the same for the other criteria, when values are present.
aPercentage of 200 small-budded cells with  4 actin patches in the mother   SEP (standard error of proportion   sqrt(p*(1   p)/n). Values statistically dif-
ferent (P   0.05) from that of wt are indicated with an asterisk.
bGrowth of 10-fold serial dilutions, relative to wt.     indicates similar to wt.    and a   indicate 10- and 100-fold decrease in growth, respectively. 0
is no growth.
cThe pattern of immunofluorescence staining is listed as wt, diffuse, or partial, corresponding to representative images in Fig. 6. ND, not determined.
dThe intensity of patch staining in buds is indicated as     (bright) to   (dim).572 The Journal of Cell Biology | Volume 164, Number 4, 2004
ping is hypothesized to be a physiologically relevant function
of CP. To test this hypothesis, we asked whether actin cap-
ping, as measured biochemically in vitro, correlates with the
ability of CP to function normally in vivo. Second, to ad-
dress the role of capping in the assembly of the actin patch,
we determined the localization of these CP mutant proteins
in vivo. In the sarcomere of striated muscle, CP (CapZ) ap-
pears to bind first to a periodic scaffold, independently of
actin. Then, CP may capture or nucleate an actin filament
(Schafer et al., 1993, 1995). On the other hand, in the den-
dritic nucleation model for lamellipodial protrusion in ani-
mal cells (Pollard and Borisy, 2003), CP caps older barbed
ends after they have formed, which “funnels” actin polymer-
ization to the new ends near the membrane (Carlier and
Pantaloni, 1997). We asked which model applies to the
yeast actin patch.
To test function in vivo, we first measured the ability of
all the CP mutations to rescue two phenotypes characteristic
of null mutations—depolarization of the actin cytoskeleton
and synthetic lethality with null mutations in the fimbrin
gene  SAC6. The assays consisted of staining cells with
rhodamine-phalloidin to reveal the actin distribution and
growing strains on plates after plasmid shuffle in a sac6 back-
ground (Table II). Next, CP mutant proteins were localized
by anti-CP staining, using rhodamine-phalloidin as a second
label to reveal actin patches (Fig. 6).
For CP  , the mutant with deletion of the entire 30-
aa tentacle, Cap1 239–268, showed no rescue of either
null mutant phenotype (Table II). An 18-aa truncation,
Cap1 251–268, also showed no rescue in either assay, but
an 11-aa truncation, Cap1 258–268, showed partial rescue
in both assays. Regarding localization, CP was diffuse
throughout the cytoplasm and was not concentrated at
patches in Cap1 239–268 and Cap1 251–268 cells (Fig.
6, arrowheads), whereas CP localized normally to patches in
Cap1 258–268 cells (unpublished data).
To assess the importance of the amphipathic  -helical re-
gion of the Cap1 tentacle (W251–S257) for function in
vivo, we changed single aa residues within that region. The
conserved residues Trp251, Ala254, and Ile255 are found
Figure 6. Localization of F-actin and CP in mutants. Representative images of the results for key Cap1 mutations, as indicated. Arrows indicate 
examples of CP colocalization with cortical actin patches; arrowheads indicate examples of colocalization failure. Bar, 5  m.Capping protein binding to actin | Kim et al. 573
on the hydrophobic side. W251A and W251R mutations
produced large (but not complete) loss of function in both
assays (Table II). W251F was similar to wt. Changing
Ala254 or Ile255 to Arg resulted in wt levels of function in
both assays (Table II). We also changed Gly252, Ser253,
Gly256, and Ser257 to Arg, one at a time; none of the muta-
tions showed any difference compared with wt. Thus, W251
is the only residue in the helical domain necessary for CP
function in vivo. CP localization in the W251A and W251R
strains showed decreased intensity of patch staining with in-
creased diffuse cytoplasmic staining (Fig. 6).
We tested the importance of three residues near the pro-
posed pivot point of the Cap1 tentacle: Arg239, Arg240,
and Arg241 (Fig. 1 B). Residues Arg 240 and Arg 241 are
located on the surface of the protein, with their side chains
exposed to solvent (Fig. 1 A; only Arg240 was indicated).
The side chain of Arg239 is oriented toward the body of the
protein, and Arg239 makes close contacts with surrounding
residues. Thus, Arg239 may anchor the tentacle and be nec-
essary for pivoting. An R239A mutation produced severe
loss of function in both assays, whereas R240A and R241A
mutations had no effect (Table II). A double mutant,
RR239 240AA, showed complete loss of function, as did the
single change of charge mutations R239E and R240E (Ta-
ble II). CP was localized normally in R240A and R241A
strains. The R239A mutant showed increased diffuse stain-
ing as well as patch localization; the patch staining intensity
was much less than that of wt (Fig. 6). RR239 240AA,
R239E, and R240E showed diffuse CP staining (Table II).
For CP  , we truncated the entire proposed tentacle by
introducing a stop site that removed 27 residues, creating
Cap2 261–287. The mutation provided complete rescue of
both null mutant phenotypes (Table II). The localization
of this mutant CP was normal. A shorter truncation,
Cap2 264–287, produced similar results, as did the point
mutation Cap2 K261A.
When a mutation produced loss of function in vivo, we
asked whether the level of the mutant CP was normal, to
consider loss of protein as a trivial explanation for loss of
function. By immunoblots, both CP subunits were ex-
pressed at approximately normal levels in all CP mutants
with any loss of function (Fig. 7).
Additional tests of CP function in vivo
To address the question of whether the actin-binding activ-
ity of CP is necessary for all its functions in vivo, we com-
pared the phenotype of a CP actin-binding mutant with that
of a null mutant in four additional assays.
First, twinfilin is located at the actin patch and binds di-
rectly to CP (Palmgren et al., 2001). In CP null mutants,
twinfilin localization at patches is greatly decreased (Palm-
gren et al., 2001). Here, we found that twinfilin localiza-
tion to actin patches in Cap1 239–268 was also greatly de-
creased (Fig. 8).
Second, we assayed addition of rhodamine-actin to per-
meabilized cells, which is increased in CP null mutants (Li et
al., 1995). The Cap1 239–268 mutant showed increased
addition of rhodamine actin, similar to that in a cap1 null
mutant. We added 0.5  M exogenous rhodamine-actin to
permeabilized cells. Levels of rhodamine-actin assembly
were quantified by averaging fluorescence intensities from
buds of small-budded cells. For Cap1 239–268, the level
was 1.7 times that of wt, and cap1  was 2.2 times that of wt
(Fig. 9 A). We also graphed the rhodamine fluorescence in-
tensities as a histogram for both whole buds (Fig. 9 B) and
individual patches (Fig. 9 C). The distribution of fluores-
cence intensities was higher in both cap1 mutants, relative to
that of wt, for both whole buds and individual patches. The
two mutants were similar to each other.
Loss of CP function might increase the number of barbed
ends, and added rhodamine-actin may polymerize at free
barbed ends. In the assay, rhodamine-actin is present at a con-
centration greater than the barbed end critical concentration
and near that of the pointed end. To determine how much of
the rhodamine-actin addition here was caused by free barbed
ends, we added purified CP at 500 nM to the permeabilized
cells before adding rhodamine-actin. CP treatments in the
Figure 7. Immunoblot of CP in whole-cell extracts of yeast mutant 
strains with decreased CP function in vivo. The same amount (20  g, 
determined by Bradford assay of the cell lysate) of total protein was 
loaded on a 10% SDS–polyacrylamide gel, blotted, and probed with 
antibodies against Cap1 or Cap2. Figure 8. Twinfilin localization to cortical actin patches in a CP 
actin-binding mutant. The localization of twinfilin (A and C) and 
actin (B and D) was examined in wt (A and B) and Cap1  239–268 
(C and D) strains. Bar, 5  m. Arrows indicate cortical actin patches.574 The Journal of Cell Biology | Volume 164, Number 4, 2004
two cap1 mutant strains decreased the level of actin incorpo-
ration by a significant amount, but not to the level of a con-
trol wt strain without CP (Fig. 9 A). For wt cells, CP treat-
ment also decreased the amount of actin incorporation, but
only by a small amount. Thus, the cap1 mutants do appear to
have increased numbers of free barbed ends, and the actin-
binding mutant was similar to the null mutant.
Next, we measured the levels of total actin and F-actin. By
immunoblot, the level of total actin was the same in wt, CP
null, and CP actin-binding mutant cells (Fig. 10 A). We
measured F-actin by rhodamine-phalloidin binding assays,
examining either a population of cells with a fluorometer or
individual cells with a fluorescence microscope. Under both
methods, the level of F-actin in both mutants was increased
by similar amounts. By fluorometry, the level was  1.4 times
that of wt (Fig. 10 B), and by microscopy, the level was  1.3
times that of wt (Fig. 10 C). These results differ from a previ-
ous result from our lab (Karpova et al., 1995), where the
F-actin level as measured by fluorometry and rhodamine-
phalloidin binding went down. As part of this paper, we re-
peated those experiments carefully, and we also used fluores-
cence microscopy as an independent approach. We do not
have a good understanding of the basis for the discrepancy.
Combined with the previous result that the CP mutants had
increased numbers of free barbed ends, the increase in F-actin
implies that the actin monomer concentration is greater than
the barbed end critical concentration, which is consistent
with our understanding of actin assembly in general.
Finally, we measured the motility of cortical actin patches.
We used Sac6-GFP to label the patches, collected movies of
Figure 9. Rhodamine-actin incorporation into permeabilized cells. 
0.5  M rhodamine-actin was added to permeabilized cells for 10 
min. Small-budded cells were viewed by fluorescence microscopy. 
(A) The mean intensity of fluorescence associated with the entire 
bud was quantified. The error bar is SEM. Asterisks mark cases 
where the difference between the mutant and wt is statistically 
significant (P   0.05). B and C are histograms of the intensity of 
fluorescence of the entire bud (B) and of individual patches in the 
bud (C). The unit of fluorescence intensity is arbitrary.
Figure 10. Quantitation of actin in CP mutants. (A) Immunoblot of 
actin in whole-cell extracts of yeast strains. The same amount (20  g) 
of total protein was loaded. (B) Bars represent the mean value of 
bound rhodamine-phalloidin fluorescence for a cell population 
measured in a fluorometer. The values for each strain were normalized 
for total protein content, and wt was set at 100%. (C) Bars represent 
the mean value of bound rhodamine-phalloidin fluorescence measured 
for individual cells in a fluorescence microscope. The error bar is 
SEM. Asterisks marks cases where the difference between the mutant 
and wt is statistically significant (P   0.05).Capping protein binding to actin | Kim et al. 575
patches, and tracked the patches with the assistance of com-
puter software. The speed of the patches was very similar in
wt,  cap1 , and Cap1 239–268 strains (Fig. 11; 0.1–1.3
 m/s). To analyze the motion of the patches further, we
plotted the mean squared distance against time for all the
tracks. For all three strains the plots were linear, indicating
that the motion is largely random, and the slopes of the lin-
ear portions were similar, confirming that the speeds are
similar (unpublished data).
Discussion
In this paper, we have defined the structural basis for actin
capping by CP, and we have used this information to provide
evidence that actin capping is the major physiological func-
tion of CP, sufficient to account for all null mutant pheno-
types. Also, actin capping is necessary for the localization of
CP to actin patches, consistent with the dendritic nucleation
model for actin assembly (Pollard and Borisy, 2003).
The tentacle model for CP binding to actin
An atomic structure for chicken CP was recently solved us-
ing x-ray crystallography (Yamashita et al., 2003). In the
chicken CP structure, the COOH-terminal region of the  
subunit is largely exposed to solvent, but is folded down
onto the surface of the protein with an apparent hydropho-
bic interaction between the body and the COOH-terminal
region. In contrast, the COOH-terminal region of the CP  
subunit is extended, lacking any interactions with the body
of the protein. These features, coupled with the symmetry of
the barbed end of the actin filament, inspired a tentacle
model in which the COOH-terminal regions are mobile, ex-
tend out from the body of the protein, and bind to the
barbed end (Yamashita et al., 2003). The actin-binding as-
pect of this model was supported by experiments with
chicken CP (Wear et al., 2003).
CP is highly conserved, so we constructed a homology
model for yeast CP based on the chicken structure. We
tested the actin-binding aspect of the tentacle model by de-
leting the proposed tentacles and measuring actin-capping
activity in vitro. Loss of both COOH-terminal regions
caused a complete loss of actin-binding activity. Loss of the
  COOH-terminal region caused a large decrease in actin-
capping activity (8,600-fold), and loss of the   COOH-ter-
minal region caused a small decrease in actin-capping activ-
ity (eightfold). Single amino acid changes confirmed the pri-
mary importance of the    COOH-terminal region, and
demonstrated the importance of residues on the hydropho-
bic side of an amphipathic helix in the region and at a po-
tential pivot point where the proposed tentacle meets the
body of the protein. The proposed   tentacle alone, as a syn-
thetic peptide, displayed actin-capping and monomer-bind-
ing activities, although they were weak. Based on the obser-
vation that a single COOH-terminal region, either free or
attached to CP, is able to cap, we suggest that the COOH-
terminal regions bind to interfaces between actin subunits in
the filament, as discussed previously (Wear et al., 2003).
These results test and confirm the actin-binding aspect of
the tentacle model, but the experiments do not test the pre-
diction that the COOH-terminal regions are mobile and ex-
tend away from the body of CP to bind the barbed end. In-
deed, recent analyses of the interaction of S100 protein with
chicken CP suggest that the COOH-terminal region of CP
  is not extended (Wear and Cooper, 2004).
Physiological function and localization of CP
We used these actin-binding mutants to test two hypothe-
ses—that CP’s major physiological function is to bind actin,
and that CP is present at cortical actin patches because it
binds actin. We found that CP actin-binding mutants had
the same phenotype as CP null mutants for every phenotype
assayed—polarization of the actin cytoskeleton, synthetic le-
thality with sac6, twinfilin localization, incorporation of
rhodamine-actin into permeabilized cells, levels of F-actin
and total actin, and actin patch motility. Together, these re-
sults show that CP’s actin-capping activity is necessary for
CP to function in vivo. CP does possess other biochemical
activities, such as binding twinfilin (Palmgren et al., 2001),
and those may also be important for function in vivo. The
results here do not argue against that possibility, which we
see as likely.
We also localized the CP actin-binding mutant proteins in
vivo, performing a double localization with actin patches.
The order of severity of the mutations for loss of actin bind-
ing in vitro was essentially the same as the order of severity
for loss of function in vivo and for localization to actin
Figure 11. Histogram of speeds of actin patches 
moving in CP mutants and wt. The percentage of 
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patches (Table II). The results suggest that actin filaments
with free barbed ends are formed first and are then capped
by CP, which agrees with the hypothesis that actin filaments
with free barbed ends are nucleated by the action of Arp2/3
complex (Machesky and Gould, 1999; Pollard and Borisy,
2003). Actin patches are still present in CP null mutants
(Amatruda et al., 1990), also consistent with CP localization
being “downstream” of actin assembly.
One interesting aspect of these results was how much of a
defect in CP’s actin-capping activity was compatible with
apparently normal function and localization—at least 10-
fold. One interpretation of this result is that the cell contains
a 10-fold excess of CP, so that actin filaments are still capped
in adequate numbers and with adequate speed for viability
and growth in these CP mutants.
Comparison of yeast and chicken CP results
A recent analysis of actin-binding mutations for chicken CP
had results qualitatively similar to those here for yeast CP
(Wear et al., 2003). Loss of both COOH-terminal regions
produced a complete loss of actin binding, and the   COOH
terminus was more important than the   COOH terminus.
Previous experiments, performed without the benefit of the
CP crystal structure or bacterial expression system, suggested
that yeast and chicken CP might bind actin differently (Hug
et al., 1992; Sizonenko et al., 1996). Our current analysis
shows that this is not the case. The high degree of sequence
conservation among CP subunits from various eukaryotes
suggests that this model for binding actin may apply to other
CPs. Indeed, nematode CP can function in yeast, rescuing
null mutant phenotypes (Waddle et al., 1993).
Implications of the biochemical results for actin 
assembly in vivo
One interesting and potentially important difference be-
tween yeast and chicken CP is that yeast CP binds actin less
well than does chicken CP, by a factor of  10 in Kd. This
difference holds for actin from yeast as well as from muscle.
Moreover, the off-rate constant for the dissociation of yeast
CP from the actin filament is higher than that of chicken CP
by a factor of 10 or more. Therefore, the half-life of a capped
actin filament in yeast should be 22 s, compared with 30
min in vertebrates (Schafer et al., 1996).
One can also calculate the expected half-life of a free
barbed end, and how much that barbed end should grow be-
fore being capped. We confirmed previous values for cellular
content of actin and CP in yeast (Amatruda and Cooper,
1992; Nefsky and Bretscher, 1992; Karpova et al., 1995).
The total concentration of actin in the cytoplasm is 5.3  M,
and the total concentration of CP is 1.3  M (see Materials
and methods). To estimate the half-life of a new free barbed
end until the time when it is bound by CP, one must assume
a value for the concentration of free cytoplasmic CP. Most
CP appears to be localized at patches in images of wt cells
(Fig. 6; Amatruda and Cooper, 1992), and the localization
results here indicate that CP found at patches is indeed
bound to actin. Thus, one might estimate the free CP cyto-
plasmic concentration at 10% of the total, or 0.13  M. With
the on-rate constant of 9  M
 1 s
 1 for yeast CP and yeast ac-
tin (Table I), the rate of capping is 9  M
 1 s
 1   0.13
 M   1.17 s
 1, which converts to a half-life of 0.4 s. The to-
tal actin concentration is 5.3  M, and a conservative estimate
of the actin monomer concentration might be 0.5  M, near
the critical concentration for the pointed end. At an actin mono-
mer concentration of 0.5  M, a free barbed end would grow
by two subunits, given the actin elongation rate constants
and the half-life of 0.4 s. This value of two subunits is proba-
bly a lower limit. The actin monomer concentration may be
higher if pointed ends are capped by Arp2/3 complex. Also,
the effective actin monomer concentration in the patch may
be higher if proteins that bind monomer in the patch are able
to “deliver” that monomer to a free barbed end. Even so, this
analysis suggests that actin filaments of patches are short,
which agrees with the size of patches (Mulholland et al.,
1994). Actin cables of yeast presumably contain longer actin
filaments, bundled together, which were nucleated by form-
ins. Formins remain with the barbed end of the nucleated fil-
ament and protect it from capping by capping protein (Zig-
mond et al., 2003), which may account for the increased
filament length in cables versus patches.
The results here also address the question of how the den-
dritic nucleation model (Pollard and Borisy, 2003) applies
to actin patch assembly and motility, especially the funnel-
ing model for CP’s role in dendritic nucleation (Carlier and
Pantaloni, 1997). Previous papers showed that Arp2/3 com-
plex and cofilin activity are important for actin patch assem-
bly and motility (Lappalainen and Drubin, 1997; Winter et
al., 1997; Idrissi et al., 2002), and that actin polymerization
is important for patch movement (Carlsson et al., 2002).
These findings are in accord with the dendritic nucleation
model. Here, we found that the loss of CP’s actin-capping
activity led to an increase in free barbed ends per patch and
per small bud, based on addition of rhodamine-actin to per-
meabilized cells. This result is also predicted by the dendritic
nucleation model.
The funneling model for CP’s role in dendritic nucle-
ation predicts that the absence of CP should cause de-
creased assembly and motility at the locations of Arp2/3-
induced nucleation, secondary to increased actin assembly
at other locations of barbed ends in the cell. Here, CP
actin-binding and null mutants showed an increase in
the level of F-actin per cell and per bud, based on rhoda-
mine-phalloidin binding, in agreement with the funneling
model. However, CP actin-binding and null mutants
showed no change in actin patch motility, based on mea-
surements of individual patch speed, which runs counter to
the model. One potential explanation for this result is that
yeast cells may not have a substantial pool of barbed ends
in the cytoplasm in general, outside of patches and perhaps
cable ends, and thus do not need CP to cap those ends to
keep the actin monomer concentration high enough to
support actin assembly at patches. Another possibility is
that some other factor caps barbed ends. Aip1 has been re-
ported to cap barbed ends as a complex with cofilin (Cof1)
in Xenopus and Saccharomyces (Okada et al., 2002; Balcer et
al., 2003); however, an aip1 cap2 double-null mutant
shows only a minimal synthetic effect in terms of growth
(Rodal et al., 1999). Biochemical and sequence analyses
have not revealed any other types of barbed end capping
proteins, such as gelsolins, in Saccharomyces.Capping protein binding to actin | Kim et al. 577
Materials and methods
Chemicals and reagents were from Fisher Scientific and Sigma-Aldrich, un-
less stated otherwise. Synthetic peptides corresponding to the COOH-ter-
minal 30 aa and 28 aa of yeast Cap1 and Cap2, called Cap1 C-30 and
Cap2 C-28, respectively, were obtained from Biomolecules Midwest. They
were purified by reverse-phase HPLC, and their sequence was verified by
electrospray mass spectrometry.
Oligonucleotide primers are listed in Table III, CP mutant plasmids in
Table IV, and yeast strains in Table V. Oligonucleotide-mediated site-directed
mutagenesis was performed using the QuikChange
® Site-Directed Mu-
tagenesis Kit (Stratagene). Mutations were verified by DNA sequencing.
Homology modeling of yeast CP
The three-dimensional model of yeast CP was built with SWISS-MODEL
(Guex and Peitsch, 1997). Cap1 was built by providing the Cap1 sequence
(Swiss-Prot: P28945) with the coordinates of the chicken CP   subunit
(PDB code: 1IZN) as a template; Cap2 by providing the Cap2 sequence
(Swiss-Prot: P13517) with the coordinates of the chicken CP  1 subunit.
Residues 268 to the COOH terminus of Cap2 were not modeled by
SWISS-MODEL because the sequence homology with the chicken CP  
subunit in this region is fairly low. Residues 268–273 of Cap2 are missing
in the yeast CP homology model because they reside in a loop region and
could not be modeled manually. Structures for the residues 274–287 of
Cap2 were built by manually replacing the residues of chicken  1 with
those of yeast Cap2 using the graphic program TURBO-FRODO (A. Rous-
sel and C. Camillau, AFMB, CNRS, Marseilles, France) based on the se-
quence alignment.
Bacterial expression of CP
A tandem bacterial expression plasmid to simultaneously express Cap1
and Cap2 was constructed in pET-3d (Novagen) (Studier et al., 1990) fol-
lowing the strategy developed by Obinata and colleagues (Soeno et al.,
1998). The coding regions of CAP1 and CAP2 were amplified by PCR us-
ing wt yeast genomic DNA as a template. Oligonucleotides MAW-33 and
MAW-34 were used for CAP1, and MAW-48 and MAW-36 were used for
CAP2 (Table III). The amplified PCR products were gel purified and sub-
cloned into separate pET-3d vectors; the resulting constructs were verified
by DNA sequencing in both directions. The CAP1 PCR product was di-
gested with AlfIII and BamHI, and then ligated into pET-3d digested with
NcoI and BamHI, to make pBJ 1353. The CAP2 PCR product was digested
with BspHI and BamHI, and then ligated into pET-3d digested with NcoI
and BamHI, to make pBJ 1354. The tandem expression vector pBJ 1355,
allowing simultaneous expression of Cap1p and Cap2p, was then con-
structed as follows: the DNA sequences corresponding to the T7 promoter
region, the ribosome-binding site, the coding sequence of CAP2, and the
T7 terminator region were amplified by PCR using the forward primer
MAW-47 and the reverse primer MAW-46 with pBJ 1354 as template. The
amplified product was gel purified, digested with HindIII, and subcloned
into pBJ 1353 digested with HindIII. The orientation and sequence of the
CAP2 insert was verified by restriction digest and DNA sequencing of the
coding region of CAP2.
CP mutants were expressed in bacteria and purified to homogeneity as
described previously (Wear et al., 2003), with minor modifications. Yeast
actin was purified from strain YJC 0094 (Table V) as described previously
(Goode, 2002). Muscle actin was purified and labeled with pyrene as de-
scribed in Wear et al. (2003). Actin polymerization assays, both kinetic and
steady state, were performed as described in Wear et al. (2003). Kinetic rate
constants were determined from the time course of seeded actin assembly
using Berkeley Madonna, as described previously (Wear et al., 2003).
Yeast CP expression mutants: mutagenesis and
strain construction
Plasmids expressing mutant forms of Cap1 or Cap2 from their endogenous
promoters (Table IV) were introduced into cap1  and cap2  strains (YJC
0390 and YJC 0171, respectively) and into cap1  sac6  CEN::CAP1 and
cap2  sac6  CEN::CAP2 strains (YJC 0596 and YJC 0922, respectively).
Mutations of CAP1
The template for mutagenesis was a CAP1 expression plasmid (pBJ 217)
containing CAP1 and its flanking sequences in the HIS3 CEN plasmid pRS
313 (Sikorski and Hieter, 1989). Cap1 258–268: deletion of Cap1 resi-
dues Y258–K268. Bases 1970–1971 were changed from AT to GA with
oligonucleotides KKT-07 and KKT-08. Cap1 251–268: base 1950 was
changed from G to A with oligonucleotides KKT-09 and KKT-10. Cap1-
 239–268: base 1912 was changed from A to T with oligonucleotides
KKT-11 and KKT-12. Cap1 R239A: bases 1912–1914 were changed from
AGA to GCT with primers KKT-01 and KKT-02. Cap1 R240A: bases 1915–
1917 were changed from AGA to GCT with oligonucleotides KKT-03 and
KKT-04. Cap1 R240E: bases 1915–1916 were changed from AG to GA
with oligonucleotides KKT-13 and KKT-14. Cap1 RR239, 240AA: bases
1912–1917 were changed from AGAAGA to GCTGCT with oligonu-
cleotides KKT-05 and KKT-06. Cap1 W251R: bases 1948–1950 were
changed from TGG to CGT with oligonucleotides KKT-17 and KKT-18.
Cap1 W251A: bases 1948–1950 were changed from TGG to GCT with oli-
gonucleotides KKT-77 and KKT-78. Cap1 W251F: bases 1949–1950 were
changed from GG to TC with oligonucleotides KKT-89 and KKT-90. Cap1
G252R: base 1951 was changed from G to C with oligonucleotides KKT-
Table III. Sequences of oligonucleotides, listed 5  to 3 
Number Sequence
KKT-01 CAGTTTAAGGCCTTAGCTAGAAGATTACCAGTCACG
KKT-02 CGTGACTGGTAATCTTCTAGCTAAGGCCTTAAACTG
KKT-03 CAGTTTAAGGCCTTAAGAGCTAGATTACCAGTCACG
KKT-04 CGTGACTGGTAATCTAGCTCTTAAGGCCTTAAACTG
KKT-05 CAGTTTAAGGCCTTAGCTGCTAGATTACCAGTCACG
KKT-06 CGTGACTGGTAATCTAGCAGCTAAGGCCTTAAACTG
KKT-07 GCGATTGGCAGTTGAAGATTGGGTAAG
KKT-08 CTTACCCAATCTTCAACTGCCAATCGC
KKT-09 CGAGATCCAAAATTAACTGAGGTAGTGCGATTGGC
KKT-10 GCCAATCGCACTACCTCAGTTAATTTTGGATCTCG
KKT-11 CAGTTTAAGGCCTTATGAAGAAGATTACCAGTC
KKT-12 GACTGGTAATCTTCTTCATAAGGCCTTAAACTG
KKT-13 CAGTTTAAGGCCTTAAGAGAAAGATTACCAGTCACG
KKT-14 CGTGACTGGTAATCTTTCTCTTAAGGCCTTAAACTG
KKT-17 CGAGATCCAAAATTAACCGTGGTAGTGCGATTGGC
KKT-18 GCCAATCGCACTACCACGGTTAATTTTGGATCTCG
KKT-19 CTGGGGTAGTCGTATTGGCAGTTATAG
KKT-20 CTATAACTGCCAATACGACTACCCCAG
KKT-21 GGGGTAGTGCGCGTATTGGCAGTTATAG
KKT-22 CTATAACTGCCAATACGCGCACTACCCC
KKT-27 CCAAACAAAGAACGCATGAATTGCTTCCTCTGCTG
KKT-28 CAGCAGAGGAAGCAATTCATGCGTTCTTTGTTTGG
KKT-29 CTTCCACCAAACAGCTAACGCAGCCATTGC
KKT-30 GCAATGGCTGCGTTAGCTGTTTGGTGGAAG
KKT-75 CAGTTTAAGGCCTTAGAAAGAAGATTACCAGTCACG
KKT-76 CGTGACTGGTAATCTTCTTTCTAAGGCCTTAAACTG
KKT-87 CGAGATCCAAAATTAACGCTGGTAGTGCGATTGGC
KKT-88 GCCAATCGCACTACCAGCGTTAATTTTGGATCTCG
KKT-89 CGAGATCCAAAATTAACTTCGGTAGTGCGATTGGC
KKT-90 GCCAATCGCACTACCGAAGTTAATTTTGGATCTCG
KKT-91 CGAGATCCAAAATTAACTGGCGTAGTGCGATTGGC
KKT-92 GCCAATCGCACTACGCCAGTTAATTTTGGATCTCG
KKT-93 CCAAAATTAACTGGGGTCGTGCGATTGGC
KKT-94 GCCAATCGCACGACCCCAGTTAATTTTGG
KKT-95 GGGGTAGTGCGATTCGTAGTTATAGATTGGG
KKT-96 CCCAATCTATAACTACGAATCGCACTACCCC
KKT-97 GGTAGTGCGATTGGCCGTTATAGATTGGG
KKT-98 CCCAATCTATAACGGCCAATCGCACTACC
KKT-113 GAGATATCTTCCACCAAACATGAAACGCAGCCATTG-
CTTCC
KKT-114 GGAAGCAATGGCTGCGTTTCATGTTTGGTGGAAGA-
TATCTC
MAW-33 CCACATGTCTAGTAGTAAATTCG
MAW-34 GCGGATCCTCATTTGCCTTCTGCCGC
MAW-36 GCGGATCCCTATAAAGACTGTAAACCTC
MAW-46 CCCAAGCTGGATATCCGGATATAGTTCC
MAW-47 CCCAAGCTTGTCCGGCGTAGAGGATCG
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91 and KKT-92. Cap1 S253R: base 1954 was changed from A to C with
oligonucleotides KKT-93 and KKT-94. Cap1 A254R: bases 1957–1959
were changed from GCG to CGT with oligonucleotides KKT-19 and KKT-
20. Cap1 I255R: bases 1960–1961 were changed from AT to CG with oli-
gonucleotides KKT-21 and KKT-22. Cap1 G256R: bases 1963–1965 were
changed from GGC to ACG with oligonucleotides KKT-95 and KKT-96.
Cap1 S257R: base 1966 was changed from A to C with oligonucleotides
KKT-97 and KKT-98.
Mutations of CAP2
The template for mutagenesis was a CAP2 expression plasmid (pBJ 119)
containing CAP2 and its flanking sequences in the LEU2 CEN plasmid pRS
315 (Sikorski and Hieter, 1989). Cap2 264–287: deletion of Cap2 resi-
dues A264 through L287. Bases 2650–2652 were changed from AAG to
TGA with oligonucleotides KKT-27 and KKT-28. Cap2 261–287: bases
2641–2643 were changed from AAG to TGA with oligonucleotides KKT-
113 and KKT-114. Cap2 K261A: bases 2641–2643 were changed from
AAG to GCT with oligonucleotides KKT-29 and KKT-30.
Electrophoresis and immunoblotting
Whole-yeast cell extracts were subjected to 10% SDS-PAGE and trans-
ferred to nitrocellulose. The membrane was blocked with 3% BSA in PBS.
Affinity-purified rabbit polyclonal antibodies against Cap1 (R13) and Cap2
(R12) were incubated for 1 h at RT. HRP-conjugated mouse anti–rabbit IgG
(Biosource International) was used at 1:40,000. To detect actin, affinity-
purified goat anti-yeast actin pAbs (G2) (Karpova et al., 1993) were used,
followed by HRP-rabbit anti–goat IgG. An ECL detection kit (Amersham
Biosciences) was used. To quantitate total cell content of CP and actin,
known quantities of purified yeast CP and actin were loaded on the gel as
standards, and the blot was scanned and analyzed by densitometry. The
number of cells loaded on the gel was calculated, and mean cell volume
was calculated from the major and minor axes of cells from the culture by
light microscopy. In two independent experiments, the total actin concen-
tration in the cytoplasm was determined to be 4.4 and 6.1  M, and the to-
tal CP concentration was 0.98 and 1.5  M.
Fluorescence microscopy
CP and actin were localized with anti-CP antibodies and rhodamine-phal-
loidin as described previously (Amatruda and Cooper, 1992) in the same
strains used to test actin patch polarization. Twinfilin was localized with
anti-twinfilin antibodies (Palmgren et al., 2001), provided by Pekka Lappa-
lainen (University of Helsinki, Helsinki, Finland). Digital images were col-
lected on an inverted microscope (model IX70; Olympus) with a PlanApo
100  oil (NA 1.4) objective lens and a cooled CCD camera (Dage-MTI),
using NIH Image software on a PowerMac G4.
Assays for null mutant phenotypes
For actin patch polarization, mutated CP genes on plasmids were trans-
fected into strains carrying cap1 or cap2 null mutations YJC 0390 or YJC
0171, respectively. Cultures were fixed and stained with rhodamine-phal-
loidin as described previously (Sizonenko et al., 1996). As a quantitative
measure of actin cytoskeleton polarization, we counted the number of ac-
tin patches in the mother portion of small-budded cells and defined polar-
ized cells as having  4 patches in the mother. For sac6 synthetic lethality,
mutated CP genes on URA3 plasmids were shuffled as described previ-
ously (Sizonenko et al., 1996). Serial 10-fold dilutions of multiple indepen-
dent transformants were grown on selective media and were replica plated
onto 5-fluoro-orotic acid.
Rhodamine-actin and permeabilized cells
Addition of 0.5  M rhodamine-labeled actin to permeabilized cells was
performed as described previously (Li et al., 1995) with minor modifica-
tions. Three strains, YJC 2954 (wt), YJC 2953 (Cap1 ), and YJC 2967
(Cap1  239–268) were used (Table V). Fluorescence images were col-
lected on an inverted microscope (model IX70; Olympus) using NIH
Image software. The fluorescence intensity in specific regions (i.e.,
whole bud or single patch in bud) was measured using NIH image soft-
ware. For each dataset, 20 small-budded cells (bud size  1/3 of the
mother) from 10 different fields were chosen at random and were mea-
sured. Background intensity was measured from an equal-sized area of
each field that did not have cells, and was subtracted from the mea-
Table IV. Mutant CP plasmids
pBJ# Other name Template Primers
1370 pET-3d/Cap1 239–268 pBJ 1355 KKT 11, 12
1371 pET-3d/Cap2 264–287 pBJ 1355 KKT 27, 28
1378 pET-3d/Cap1 R239A pBJ 1355 KKT 1, 2
1385 pET-3d/Cap1 239–268/Cap2 264–287 pBJ 1355 KKT 11, 12, 27, 28
1398 pET-3d/Cap2 261–287 pBJ 1355 KKT 113, 114
1399 pET-3d/Cap1 239–268/Cap2 261–287 pBJ 1355 KKT 11, 12, 113, 114
1400 pET-3d/Cap1 W251A pBJ 1355 KKT 77, 78
1401 pBJ 217/Cap1 258–268 pBJ 217 KKT 7, 8
1402 pBJ 217/Cap1 251–268 pBJ 217 KKT 9, 10
1403 pBJ 217/Cap1 239–268 pBJ 217 KKT 11, 12
1404 pBJ 217/R239A pBJ 217 KKT 1, 2
1405 pBJ 217/R240A pBJ 217 KKT 3, 4
1406 pBJ 217/R240E pBJ 217 KKT 13, 14
1407 pBJ 217/RR239, 240AA pBJ 217 KKT 5, 6
1408 pBJ 217/W251R pBJ 217 KKT 17, 18
1409 pBJ 217/W251A pBJ 217 KKT 77, 78
1410 pBJ 217/W251F pBJ 217 KKT 89, 90
1411 pBJ 217/G252R pBJ 217 KKT 91, 92
1412 pBJ 217/S253R pBJ 217 KKT 93, 94
1413 pBJ 217/A254R pBJ 217 KKT 19, 20
1414 pBJ 217/I255R pBJ 217 KKT 21, 22
1415 pBJ 217/G256R pBJ 217 KKT 95, 96
1416 pBJ 217/S257R pBJ 217 KKT 97, 98
1417 pBJ 119/Cap2 264–287 pBJ 119 KKT 27, 28
1418 pBJ 119/Cap2 261–287 pBJ 119 KKT 113, 114
1419 pBJ 119/K261A pBJ 119 KKT 29, 30
1461 pBJ 108/Cap1 239–268 pBJ 108 KKT 11, 12
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sured intensity of the buds or patches. The average, SD, and SEM were
calculated from the 20 measurements. In some experiments, purified
yeast CP was added at 500 nM before the addition of rhodamine-actin.
The CP concentration was maintained during the incubation with
rhodamine-actin.
F-actin by fluorometry
To determine F-actin levels in wt (YJC 2954), Cap1  (YJC 2953), and
Cap1 239–268 (YJC 2967) strains, a rhodamine-phalloidin binding assay
was performed as described previously (Lillie and Brown, 1994; Karpova
et al., 1995). In brief, the total protein content of cell aliquots was mea-
sured by Bradford assay. Before staining, fixed cells were divided into
three equal aliquots. Cells were suspended in 1  PBS containing 0.2%
Triton X-100, and were stained with 0.33  M rhodamine-phalloidin (Mo-
lecular Probes, Inc.). In a control aliquot, 300  M unlabeled phalloidin
was also added (Molecular Probes, Inc.). The cells were washed twice
with 1  PBS. The bound rhodamine-phalloidin was extracted by incuba-
tion in 500  l methanol. Fluorescence intensity was measured on a spec-
trofluorometer (QuantaMaster™; Photon Technology International), with
excitation at 550 nm and emission at 580 nm. The values obtained for un-
labeled phalloidin-containing control samples were subtracted from those
obtained for the corresponding samples to correct for nonspecific binding
of labeled phalloidin.
F-actin by fluorescence microscopy
Cells were stained with rhodamine-phalloidin as described previously (Si-
zonenko et al., 1996). Fluorescence microscopy was performed as de-
scribed above, and intensities of individual cells were measured using NIH
Image software. For each dataset, 10 cells in 2–3 different fields chosen at
random were measured. Background intensity was measured from an area
of each field that did not have cells, and was subtracted.
Actin patch motility
Cortical actin patches were tracked as described previously (Carlsson et
al., 2002), using Sac6-GFP. Strain YJC 3481(SAC6-GFP-HIS3 cap1 ) was
transfected with a plasmid that expressed nothing (pBJ 82), wt CAP1 (pBJ
108), or Cap1 239–268 (pBJ 1461). We confirmed the functionality of the
genes by the polarization of the actin patches. Movies of actin patches
were collected from a single focal plane near the upper or lower surface of
the cell with a microscope system described previously (Castillon et al.,
2003). Patch movement was tracked and analyzed with custom software
(Carlsson et al., 2002). The software was adapted to Mac OS X by Jill Jean-
blanc and Kevin Schmidt in our lab, and is available from the authors.
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